Can cancer risk run in families? Two pathologists answer 4 frequently asked questions about inherited cancer.

Research from the ASCO Breakthrough global summit highlights innovations in blood tests to find cancer and using genetic markers to personalize the use of radiation therapy.

Learn how tumor marker tests can help doctors diagnose cancer and plan the best possible treatment plan for each person.

The "Your Stories" podcast series from Conquer Cancer, the ASCO Foundation, provides insight into what it’s like to conquer cancer from different viewpoints. The podcasts featured here touch on how families cope with a cancer diagnosis.

Kimberly Pena was 31 when she was diagnosed with breast cancer, the same age her mother was when she was diagnosed more than 3 decades earlier. She shares her experience with cancer, treatment, and trying to convince her family to be tested for the BRCA genetic mutation.

In this podcast interview, Dr. Allison W. Kurian talks about a recent study showing that most women with breast or ovarian cancer do not receive genetic testing.

Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.

Concerned about a family history of cancer? Learn how genetic counseling and testing can help you understand and manage your own cancer risk.

Did you know that breast cancer is the most common cancer in U.S. women, except for skin cancer? Cancer.Net Associate Editor Dr. Norah Lynn Henry shares 9 important facts about the disease.

Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.